TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
OBIO

Orchestra BioMed Holdings Inc.

Healthcare · Biotechnology

5.90$ -4.7% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow OBIO
Line item 2020 2021 2022 2023 2024 2025
– – – – – –
– +32.1% +22.7% +29.3% +7.3% +6.2%
– +36.7% +1,030.1% +123.4% +39.2% +12.8%
– -82.7% – – – –
– – -117.4% – – –
– -49.2% +115.7% -86.8% +270.5% +69.2%
– -51.7% -592.6% – +22.5% -305.8%
– – – – – –
– -140.0% – -405.3% – -100.0%
– -139.9% – -55.2% -36.9% +202.8%
– -196.5% – +9.4% -177.0% –
– – – – – –

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?